Table 2.
Differentiation stage | GO enrichment (biological process) | Gene count |
Log (q-value) |
KEGG pathway | Gene count |
Log (q-value) |
---|---|---|---|---|---|---|
Early positive response gene set | Muscle structure development | 59 | −6.72 | PI3K-Akt signaling pathway | 31 | −2.40 |
ncRNA metabolic process | 52 | −6.68 | Regulation of actin cytoskeleton | 19 | −1.39 | |
Cellular protein localization | 46 | −5.57 | MAPK signaling pathway | 17 | −0.43 | |
Ribosome biogenesis | 34 | −6.12 | DNA replication | 14 | −4.43 | |
Early negative response gene set | Actin filament-based process | 63 | −6.70 | WNT signaling pathway | 27 | −7.21 |
Response to growth factor | 57 | −5.08 | Apoptosis | 18 | −2.86 | |
Muscle structure development | 52 | −4.71 | FOXO signaling pathway | 17 | −2.74 | |
Regulation of system process | 50 | −5.51 | HIF-1 signaling pathway | 14 | −2.47 | |
Late response gene set | Cell division | 65 | −28.52 | Cell cycle | 18 | −7.29 |
Lipid biosynthetic process | 31 | −3.473 | Steroid biosynthesis | 8 | −6.08 | |
Steroid biosynthetic process | 21 | −8.212 | p53 signaling pathway | 8 | −2.12 | |
Fatty acid metabolic process | 14 | −0.713 | PPARγ signaling pathway | 7 | −1.38 |